Research and Practice in Thrombosis and Haemostasis最新文献

筛选
英文 中文
Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome—insights from a UK center 骨髓增生性肿瘤中的血小板增多和出血:探索获得性血管性血友病综合征的临床多样性和风险-来自英国中心的见解
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-07-01 DOI: 10.1016/j.rpth.2025.102954
Giulia Simini , Andrew Innes , Saravanan Vinayagam , Golzar Mobayen , Nilanthi Karawitage , Simone Claudiani , Zain Odho , Mike Laffan , Deepa J. Arachchillage
{"title":"Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome—insights from a UK center","authors":"Giulia Simini ,&nbsp;Andrew Innes ,&nbsp;Saravanan Vinayagam ,&nbsp;Golzar Mobayen ,&nbsp;Nilanthi Karawitage ,&nbsp;Simone Claudiani ,&nbsp;Zain Odho ,&nbsp;Mike Laffan ,&nbsp;Deepa J. Arachchillage","doi":"10.1016/j.rpth.2025.102954","DOIUrl":"10.1016/j.rpth.2025.102954","url":null,"abstract":"<div><h3>Background</h3><div>Myeloproliferative neoplasms (MPNs) represent a group of blood disorders characterized by myeloid cell proliferation and an associated increased risk of thrombosis and bleeding. Platelet count may have a direct link to these complications.</div></div><div><h3>Objectives</h3><div>To share our MPN clinic’s experience with hemostatic testing and bleeding outcomes in patients with platelets ≥ 800 × 10<sup>9</sup>/L.</div></div><div><h3>Methods</h3><div>This was a single-center retrospective study from May 2022 to September 2024. Clinical characteristics, treatments, and bleeding events of patients with MPN or chronic myeloid leukemia were recorded. Laboratory assessments included full blood count, renal function, coagulation profiles, platelet function test, and von Willebrand factor (VWF) assays.</div></div><div><h3>Results</h3><div>A total of 39 patients were included, majority of whom received aspirin for thrombosis prevention (76%). The study found that bleeding complications occurred in 33% of patients, with mucocutaneous bleeding being the most common. There was a trend toward bleeding in patients on aspirin (<em>P</em> = .07). However, platelet count alone did not predict bleeding risk. While some patients showed abnormal VWF function, low VWF levels were not consistently associated with increased bleeding. Interestingly, we found moderate negative correlation between baseline VWF ristocetin/antigen and activated partial thromboplastin time (<em>P</em> = .02; <em>r</em> = −.37) and prothrombin time (<em>P</em> = .009, <em>r</em> = −.45), suggesting other potential coagulation imbalances associated with bleeding diathesis in MPNs. Post cytoreduction, there was a significant increase in mean VWF ristocetin/antigen ratio (<em>P</em> = .0009).</div></div><div><h3>Conclusion</h3><div>The study illustrates the limitations of relying solely on platelet counts to estimate bleeding risk in MPN patients. Assessment of VWF activity and careful selection of antithrombotic therapy were highlighted as important considerations.</div></div>","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 5","pages":"Article 102954"},"PeriodicalIF":3.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of heavy menstrual bleeding in a multidisciplinary young women’s clinic: a Dutch experience 多学科青年妇女诊所经期大出血的管理:荷兰经验
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-07-01 DOI: 10.1016/j.rpth.2025.102959
Yara Dixon , Bart Kabboord , Carla Groenestein-Sondaal , Marieke J.H.A. Kruip , Carolien van der Velden , Greta Mulders , C. Heleen van Ommen
{"title":"Management of heavy menstrual bleeding in a multidisciplinary young women’s clinic: a Dutch experience","authors":"Yara Dixon ,&nbsp;Bart Kabboord ,&nbsp;Carla Groenestein-Sondaal ,&nbsp;Marieke J.H.A. Kruip ,&nbsp;Carolien van der Velden ,&nbsp;Greta Mulders ,&nbsp;C. Heleen van Ommen","doi":"10.1016/j.rpth.2025.102959","DOIUrl":"10.1016/j.rpth.2025.102959","url":null,"abstract":"<div><h3>Background</h3><div>Heavy menstrual bleeding (HMB) is common in young women. It may lead to iron deficiency with or without anemia, decreased school, work, sport, and social participation, and may be the first sign of underlying bleeding disorders (BDs).</div></div><div><h3>Objectives</h3><div>To study the prevalence of BDs, initial and effective management of HMB and iron deficiency (anemia) in young women referred to a tertiary multidisciplinary HMB clinic.</div></div><div><h3>Methods</h3><div>This was a retrospective, single-center chart review evaluating patients aged ≤25 years who visited the multidisciplinary HMB clinic between March 2018 and December 2023.</div></div><div><h3>Results</h3><div>In total, 200 patients (median age, 15 years) were included. At first consultation, BD was already diagnosed in 47 (24%) patients, particularly von Willebrand disease (<em>n</em> = 27). In 32 of 153 (21%) remaining patients, a new BD was diagnosed (von Willebrand disease, <em>n</em> = 21; platelet aggregation defect, <em>n</em> = 8). Initial therapy of HMB mainly consisted of tranexamic acid with (<em>n</em> = 52, 26%) or without (<em>n</em> = 50, 30%) combined oral contraceptive pill. In 60 patients (30%), initial therapy was effective. Effective HMB management was mostly achieved with tranexamic acid combined with a combined oral contraceptive pill (<em>n</em> = 75, 38%) after a median of 1 treatment change (range, 0-10). Iron deficiency was present in 52% of patients, with approximately half having anemia. Treatment consisted of oral and/or intravenous iron supplementation in 77 patients and red blood cell transfusion in 9 patients.</div></div><div><h3>Conclusion</h3><div>BDs and iron deficiency (anemia) were common in young women with HMB. Multiple treatment strategies were needed to achieve an acceptable outcome. A multidisciplinary approach may offer complementary expertise in this patient group.</div></div>","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 5","pages":"Article 102959"},"PeriodicalIF":3.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144634332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A brief comparison of human factor XII-Ala188 and factor XII-Pro188 人因子XII-Ala188与XII-Pro188的简要比较
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-07-01 DOI: 10.1016/j.rpth.2025.102957
Aleksandr Shamanaev, David Gailani
{"title":"A brief comparison of human factor XII-Ala188 and factor XII-Pro188","authors":"Aleksandr Shamanaev,&nbsp;David Gailani","doi":"10.1016/j.rpth.2025.102957","DOIUrl":"10.1016/j.rpth.2025.102957","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 5","pages":"Article 102957"},"PeriodicalIF":3.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144634333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aims & Scope 目标及范围
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-06-01 DOI: 10.1016/S2475-0379(25)00261-4
{"title":"Aims & Scope","authors":"","doi":"10.1016/S2475-0379(25)00261-4","DOIUrl":"10.1016/S2475-0379(25)00261-4","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 102937"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144364499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2025 Oral Communications Abstracts 2025口头交际文摘
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-06-01 DOI: 10.1016/j.rpth.2025.102925
{"title":"2025 Oral Communications Abstracts","authors":"","doi":"10.1016/j.rpth.2025.102925","DOIUrl":"10.1016/j.rpth.2025.102925","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 102925"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144365078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2025 Late Breakthrough Abstracts 2025年晚期突破
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-06-01 DOI: 10.1016/j.rpth.2025.102931
{"title":"2025 Late Breakthrough Abstracts","authors":"","doi":"10.1016/j.rpth.2025.102931","DOIUrl":"10.1016/j.rpth.2025.102931","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 102931"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144365069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2025 Poster Abstracts Part 2 2025海报摘要第二部分
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-06-01 DOI: 10.1016/j.rpth.2025.102930
{"title":"2025 Poster Abstracts Part 2","authors":"","doi":"10.1016/j.rpth.2025.102930","DOIUrl":"10.1016/j.rpth.2025.102930","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 102930"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144364498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2025 Poster Abstracts Part 1 2025海报摘要第一部分
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-06-01 DOI: 10.1016/j.rpth.2025.102923
{"title":"2025 Poster Abstracts Part 1","authors":"","doi":"10.1016/j.rpth.2025.102923","DOIUrl":"10.1016/j.rpth.2025.102923","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 102923"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144365079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
99 Nonadherence to Early Discharge in Low-Risk Pulmonary Embolism: Insights from an Anticoagulation Stewardship Program in Latin America 低风险肺栓塞的早期出院不依从:来自拉丁美洲抗凝管理项目的见解
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-05-01 DOI: 10.1016/j.rpth.2025.102804
Santiago Méndez Salazar , Paula Ruiz-Talero , Oscar Muñoz , Pilar Alarcón Robles , Karen Navarro Pérez , Alice Salamanca
{"title":"99 Nonadherence to Early Discharge in Low-Risk Pulmonary Embolism: Insights from an Anticoagulation Stewardship Program in Latin America","authors":"Santiago Méndez Salazar ,&nbsp;Paula Ruiz-Talero ,&nbsp;Oscar Muñoz ,&nbsp;Pilar Alarcón Robles ,&nbsp;Karen Navarro Pérez ,&nbsp;Alice Salamanca","doi":"10.1016/j.rpth.2025.102804","DOIUrl":"10.1016/j.rpth.2025.102804","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 102804"},"PeriodicalIF":3.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144202996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
186 Anticoagulation Stewardship Using a Direct Oral Anticoagulation Dashboard to Reduce Incorrect Prescribing 186使用直接口服抗凝仪表板减少不正确处方的抗凝管理
IF 3.4 3区 医学
Research and Practice in Thrombosis and Haemostasis Pub Date : 2025-05-01 DOI: 10.1016/j.rpth.2025.102762
Jeffrey Lee , Stacy Ellsworth , Brian Haymart , Gregory Krol , Bevelry Stallings , Noelle Ryan , Michael Lanham , Geoff Barnes , Scott Kaatz
{"title":"186 Anticoagulation Stewardship Using a Direct Oral Anticoagulation Dashboard to Reduce Incorrect Prescribing","authors":"Jeffrey Lee ,&nbsp;Stacy Ellsworth ,&nbsp;Brian Haymart ,&nbsp;Gregory Krol ,&nbsp;Bevelry Stallings ,&nbsp;Noelle Ryan ,&nbsp;Michael Lanham ,&nbsp;Geoff Barnes ,&nbsp;Scott Kaatz","doi":"10.1016/j.rpth.2025.102762","DOIUrl":"10.1016/j.rpth.2025.102762","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 102762"},"PeriodicalIF":3.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144203322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信